Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases

Atherosclerosis

Volumn 189, Issue 1, 2006, Pages 206-214

  Koba, Shinji ^a   Hirano, Tsutomu ^a   Ito, Yasuki ^b   Tsunoda, Fumiyoshi ^a   Yokota, Yuuya ^a   Ban, Yoshihisa ^a   Iso, Yoshitaka ^a   Suzuki, Hiroshi ^a   Katagiri, Takashi ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DENKA COMPANY LIMITED   (Japan)

Author keywords

Apolipoprotein A1; Coronary heart disease; Coronary severity; HDL cholesterol; LDL particle size; Small dense LDL cholesterol

Indexed keywords

APOLIPOPROTEIN B; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GEL ELECTROPHORESIS; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SCORING SYSTEM;

ADULT; AGED; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 33746093347     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.12.002     Document Type: Article

References (30)

1. Griffin B.A. Lipoprotein atherogenicity: an overview of current mechanisms. P Nutr Soc 58 (1999) 163-169
2. Berneis K.K., and Krauss R.M. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 43 (2002) 1363-1379
3. Lamarche B., Lemieux I., and Després J.P. The small dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab 25 (1999) 199-211
4. Gardner C.D., Fortmann S.P., and Krauss R.M. Association of small dense low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276 (1996) 875-881
5. Koba S., and Hirano T. Small dense low-density lipoprotein in Japanese men with coronary artery disease. Ann Intern Med [Letter] 132 (2000) 762
6. Koba S., Hirano T., Yoshino G., et al. Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes. Atherosclerosis 160 (2002) 249-256
7. Koba S., Hirano T., Kondo T., et al. Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart diseases. Am Heart J 144 (2002) 1026-1035
8. Nichols A.V., Krauss R.M., and Musliner T.A. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol 128 (1986) 417-433
9. Blake G.J., Otvos J.D., Rifai N., and Ridker P.M. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 106 (2002) 1930-1937
10. Hirano T., Ito Y., Saegusa H., and Yoshino G. A novel and simple method for quantification of small dense LDL. J Lipid Res 44 (2003) 2193-2201
11. Hirano T., Ito Y., Koba S., et al. Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler Thromb Vasc Biol 24 (2004) 558-563
12. Sakaue T., Hirano T., Yoshino G., et al. Reaction of direct LDL-cholesterol assays with pure LDL fraction and IDL: comparison of three homogenous methods. Clin Chim Acta 295 (2000) 97-106
13. Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51 (1983) 606
14. St-Pierre A.C., Cantin B., Dagenais G.R., et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men, 13-year follow-up data from the Québec cardiovascular study. Aretiroscler Thromb Vasc Biol 25 (2005) 553-559
15. Zambon A., Hokanson J.E., Brown B.G., and Brunzell J.D. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation 99 (1999) 1959-1964
16. Vakkilainen J., Steiner G., Ansquer J.C., et al. on behalf of the DAIS group. Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease. The Diabetes Atherosclerosis Intervention Study (DAIS). Circulation 107 (2003) 1733-1737
17. Campos H., Moye L.A., Glasser S.P., Stampfer M.J., and Sacks F.M. Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA 286 (2001) 1468-1474
18. Ruotolo G., Ericsson C.G., Tettamanti C., et al. Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT). J Am Coll Cardiol 32 (1998) 1648-1656
19. Watts G.F., Mandalia S., Brunt JNH, et al. Independent association between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metab 42 (1993) 1461-1467
20. Rosenson R.S., Otvos J.D., and Freedman D.S. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial. Am J Cardiol 90 (2002) 89-94
21. Williams P.T., Superko H.R., Haskell W.L., et al. Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol 23 (2003) 314-321
22. Pearson T.A., Bulkley B.H., Achuff S.C., Kwiterovich P.O., and Gordis L. The association of low levels of HDL cholesterol and arterographically defined coronary artery disease. Am J Epidemiol 109 (1979) 285-295
23. Tatami R., Mabuchi H., Ueda K., et al. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiograhically determined coronary artery disease. Circulation 64 (1981) 1174-1184
24. Barboriak J.J., Anderson A.J., Rimm A.A., and King J.F. High density lipoprotein cholesterol and coronary artery occlusion. Metabolism 28 (1979) 735-738
25. Jenkins P.J., Harper R.W., and Nestel P.J. Severity of coronary atherosclerosis related to lipoprotein concentration. Br Med J 2 (1978) 388-391
26. Tornvall P., Karpe F., Carlson L.A., and Hamsten A. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis 90 (1991) 67-80
27. Reardon M.F., Nestel P.J., Craig I.H., and Harper R.W. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 71 (1985) 881-888
28. Phillips N.R., Waters D., and Havel R.J. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 88 (1993) 2762-2770
29. Blankenhorn D.H., Alaupovic P., Wickham E., Chin H.P., and Azen S.P. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation 81 (1990) 470-476
30. Ballantyne C.M. Achieving greater reductions in cardiovascular risk: lessons from statin therapy on risk measures and risk reduction. Am Heart J 148 (2004) S3-S8